Clinical implications:
Associated anomalies 50%, mainly, heterotaxy syndrome
- Chromosomal anomalies — 60%, mainly trisomy 21
- Intrauterine fetal death — 17%
- Neonatal death — 25%
- Infant death — 10%
- Survival rate — 50-60% of those without chromosomal anomalies
Management — Reconstruction of AV valve and repair of clefts at the age of 3-6 months. The mortality rate at surgery is less than 10%.
References
1) Perloff JK. The Clinical Recognition of Congenital Heart Disease. 4th edn. WB Saunders Company 1994.
2) Allan L, Hornberger LK, Sharland G. Textbook of Fetal Cardiology.Greenwich Medical Media Publishing 2000.
3) Rastelli GC, Kirklin JW, Titus JI. Anatomic observation on complete form of common atriventricular canal with special reference to atriovenricular valves. Mayo Clinic Proc 1966 41:296-308.     Â
4) Bronshtein M, Zimmer EZ. Transvaginal sonography of the normal and abnormal  fetus. Parthenon Publishing 2001.
5) Bronshtein M, Egenburg S, Auslander R, Zimmer EZ. Atrioventricular septal defect in a fetus: a false negative diagnosis in early pregnancy. Ultrasound Obstet Gynecol 2000;16:98-9
6) Paladini D, Calabro R, Palmieri S, D'Andrea T. Prenatal diagnosis of congenital heart disease and fetal karyotyping. Obstet Gynecol 1993;81:679-82.
7) TheFetus.net
Â
Â
Â